At this stage, no causal link has been established between the formation of blood clots and immunization with the Johnson & Johnson vaccine against KOVID-19, said the US Food and Drug Administration (FDA), quoted by AFP.
Everything on the topic:
Coronavirus epidemic (COVID-19) 22426
–The agency is aware of reports in the United States of severe cases of thromboembolism, sometimes associated with thrombocytopenia (decreased platelet counts), in several people after being vaccinated against KOVID-19 in the Jansen product of Johnson & Johnson), the regulator said in a statement.
“To date, we have not found a causal link with vaccination and continue to investigate and assess these cases,” the agency added.
We will inform the public as soon as we learn more, the service assures.
The European Medicines Agency (EDA) announced yesterday that it is investigating a possible link between the Johnson and Johnson vaccine and cases of blood clots.
“One case was registered in a clinical trial and three in a vaccination in the United States. One of these people died,” the European regulator added.
The Johnson & Johnson single-dose vaccine was approved for emergency use in the United States in late February, following two doses of Pfizer / Biontech and Modern.
The EAL has also approved the Johnson & Johnson vaccine and is expected to be available in the European Union this month.
:quality(80)/cdn-kiosk-api.telegraaf.nl/1f99f832-991d-11eb-9f9d-0217670beecd.jpg?resize=150%2C150&ssl=1)
